Cyclerion Therapeutics In... (CYCN)
NASDAQ: CYCN
· Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Cyclerion Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | 7.57M | -4.18M | -6.95M | -7.22M | -10.5M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M | -13.4M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65K | n/a | 17K | 48K | 48K | 48K | 118K | 258K |
Stock-Based Compensation | 114K | 114K | 122K | 138K | 184K | 181K | 103K | 159K | 379K | 426K | 1.12M | 1.66M | 1.7M | 1.77M | 2.55M | 2.41M | 2.34M | 2.31M |
Other Working Capital | n/a | 279K | 134K | 338K | 123K | -54K | -335K | -1.16M | -788K | -641K | -2.41M | 41K | 606K | -2.24M | 2.4M | 52.33M | 709K | 30.98M |
Other Non-Cash Items | -293K | n/a | n/a | -1.61M | n/a | 637K | -282K | -12.45M | 2.34M | -529K | -65K | 2.78M | 1.49M | 1.3M | -3.56M | -1K | 7.21M | -12K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.49M | n/a | n/a | 1K | n/a | n/a |
Change in Working Capital | n/a | 347K | -292K | 478K | 32K | -510K | 50K | -2.21M | -2.75M | 314K | -951K | -1.08M | 854K | -1.67M | 3.11M | 908K | 1M | -3.61M |
Operating Cash Flow | -503K | -968K | 360K | -1.72M | -1.11M | -1.87M | -1.54M | -6.93M | -6.55M | -6.21M | -7.04M | -9.91M | -10.82M | -12.84M | -8.63M | -7.92M | -5.51M | -14.46M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -7K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -10.4M | 10.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 1.46M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | n/a | 2K | 1.46M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -10.4M | 10.4M | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -7K | 2K | 1.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -130K | 1.38M | n/a | n/a | n/a | n/a | 5.02M | n/a | 5.02M | n/a | 12K | n/a | 17K | n/a | 85K | 37K | 30.63M | 27K |
Financial Cash Flow | -130K | 1.38M | n/a | n/a | n/a | n/a | n/a | n/a | 5.02M | n/a | 12K | n/a | 17K | n/a | 85K | 43K | 30.63M | 27K |
Net Cash Flow | -633K | 407K | 360K | -1.72M | -1.11M | -1.88M | -1.54M | 3.47M | -1.53M | -6.21M | -7.02M | -9.92M | -10.8M | -12.84M | -8.54M | -7.89M | 25.12M | -12.97M |
Free Cash Flow | -503K | -968K | 360K | -1.72M | -1.11M | -1.87M | -1.54M | -6.93M | -6.55M | -6.21M | -7.04M | -9.91M | -10.82M | -12.84M | -8.64M | -7.93M | -5.51M | -14.46M |